Muireann Bolger

Key details

Muireann Bolger is deputy editor of World Intellectual Property Review and Life Sciences Intellectual Property Review in London, where she covers trademarks, brands, as well as wider developments across the intellectual property sector.

She regularly attends and covers major IP conferences around the world, reporting on the latest legal, commercial and policy developments and interviewing leading figures from across the sector. She has also co-authored industry reports with leading IP organisations, including the International Trademark Association (INTA).

She is the editor of the website’s Community & Inclusion channel and the annual Influential Women in IP list, which celebrates the achievements and contributions of leading women across the IP sector.

Originally from Ireland, Muireann has nearly two decades of experience reporting on brand developments, strategy, and wider business issues.

In her current role, she writes and edits news and analysis for an international audience of IP professionals, while also championing inclusion within the profession.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 415

Articles by Muireann Bolger

Boston Scientific loses stent patent case in uni feud
Pharma
Delaware jury finds that the infringement was intentional | Verdict comes in a long-running dispute that touched upon state sovereignty.   2 February 2023
Cigna pursues trade secrets in ‘non-competes’ dispute
Pharma
Move comes as Federal Trade Commission proposes controversial ban on non-compete clauses | Former executive requested list of “top clients” on day of resignation.   31 January 2023
Blank Rome hires new patent agent for Texas office
article
Blank Rome has brought in patent agent Joseph Jackson to the firm’s IP and Technology practice group in Houston.   26 January 2023
Generics
Commission holds that the convicted former pharma head may have violated his life-long ban from working in the life sciences industry | Shkreli is already convicted of conspiring to illegally increase the price of a life-saving drug.   24 January 2023
article
Dispute concerns two of the cosmetic giant’s best-selling brands | Arguments revolved around whether the French company could be sued in the US.   12 January 2023
Americas
Subsidiary held that its arguments were same as those cited in the much-anticipated Amgen v Sanofi | Dispute concerns a cancer treatment used to treat B-cell lymphoma.   10 January 2023
article
German IP specialist gears up for UPC with experienced partner | Patent litigator previously led practice at IP boutique Meissner Bolte.   10 January 2023
Americas
Addition is a former chair of a patent practice group | New partner has expertise in complex disputes over medical devices | Barnes & Thornburg | Patterson Thuente Pedersen.   22 December 2022
Pharma
New addition comes from Fieldfisher | Practice will extend across the US, UK and Continental Europe | renewables and cleantech.   6 December 2022
Pharma
Large market for parallel or ‘grey’ imports of pharmaceuticals due to pricing differences in various countries | Govt consultation respondents unhappy with ‘lack of EU reciprocity’| Mewburn Ellis.   22 November 2022

Not finding what you're looking for, please try resetting your applied search and filters,
or try the
full site search.